Notable Insider Buys Week of 8-23-19 as Trump Tweets Scare Investors

We are throwing out AESE as this wasn't filed correctly and upon further review, it was deemed not to be an open market purchase Fossil Group insiders bought $2.2 million worth of this watch and…


Biotech and Big Pharma Dominate this Week's Insider Buys

Odonate ODT's Chairman and CEO Kevin Tang has made open market purchases of more than $36 million in so far this June, including $10 million on the spot secondary at the highest price his paid all…


Pullback in pharma has created a compelling buying opportunity

The fundamentals are good for the health care sector in general.  Recent news articles on drug pricing/gouging are not likely to effect meaningful change for the overall group dynamics in my opinion…


U.S. Drug Spending Increases Most in 13 Years to $373.9 Billion - Bloomberg Business

Often times it seems that the news, particularly economic news is out of step with the price action in the stock market.  This headline is not. No wonder healthcare is the best performing sector in…